Duale RAS-Blockade in der antihypertensiven Therapie – contra

Please copy the URL and add it into your RSS Feed Reader.

Facebook Linkedin Weibo

Dtsch Med Wochenschr 2012; 137(48): 2499
DOI: 10.1055/s-0032-1327302

Pro & Contra | Commentary

Hypertensiologie

Dual blockade of the renin-angiotensin system in hypertensive treatment: no

M. van der Giet

¹Medizinische Klinik mit SP Nephrologie, Charite – Universitätsmedizin Berlin Campus Benjamin Franklin

Further Information

Publication History

Publication Date:
20 November 2012 (online)

arterielle Hypertonie - Renin-Angiotensin-System - ONTARGET - ALTITUDE

arterial hypertension - renin-angiotensin systeme - ONTARGET - ALTITUDE

Literatur
1 Parving HH, Brenner BM, McMurray JJ et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med 2012;

MissingFormLabel
PubMed Search in Google Scholar
2 Yusuf S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-1559

MissingFormLabel
Crossref PubMed Search in Google Scholar